Pharmacoeconomics in the era of individualized medicine.
Waldman
S A
SA
Terzic
A
A
D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D015195:Drug Design; D017850:Economics, Pharmaceutical; D005838:Genotype; D006801:Humans; D008207:Lymphatic Metastasis; D025202:Molecular Diagnostic Techniques; D009367:Neoplasm Staging; D010641:Phenotype; D011237:Predictive Value of Tests; D011379:Prognosis; D014481:United States
D000970:Antineoplastic Agents